There has been progress in reaching cross-border equivalence and substituted compliance determinations – most recently, with trading venues in the EU and US – but much more remains to be done. With the final Basel capital measures set to be transposed into local regulations, the issue is likely to come to the fore once again. How can regulators and the industry solve the cross-border puzzle once and for all?
- Moderator: Scott O’Malia, Chief Executive Officer, ISDA
- Michael Davie, Global Head of Rates, LCH
- Michael Gill, Chief of Staff, Commissioner Giancarlo at U.S. Commodity Futures Trading Commission
- Kazunari Mochizuki, Director for International Financial Markets (Settlements), Japan Financial Services Agency
- Dr. Kay Swinburne MEP, Vice Chair of the Economics and Monetary Affairs Committee, European Parliament
- Petr Wagner, Finance Counselor, Delegation of the European Union to the United States
- Clare Woodman, Global Chief Operating Officer for Institutional Securities, Morgan Stanley
Latest
ISDA AGM Studio: Darcy Bradbury & Tyler Wellensiek
Darcy Bradbury, ISDA board member and managing director at D. E. Shaw, and Tyler Wellensiek, managing director and global head of market structure at BlackRock, speaks with Chris Young, ISDA’s head of US public policy, about how the post‑crisis regulatory...
Response to ESMA Guarantees
On April 30, ISDA responded to the European Securities and Markets Authority (ESMA) consultation paper on guarantees as central counterparty (CCP) collateral and certain aspects of CCP investment policy. ISDA broadly supports ESMA’s proposed draft regulatory technical standards (RTS) to...
ISDA AGM Studio: Jenny Cosco and Jason Granet
Jenny Cosco, global head of government relations and regulatory strategy at LSEG, and Jason Granet, chief investment officer at BNY, speak with Tara Kruse, ISDA’s global head of derivative products and infrastructure, about how firms can manage liquidity pressures during...
Updated OTC Derivatives Compliance Calendar
ISDA has updated its global calendar of compliance deadlines and regulatory dates for the over-the-counter (OTC) derivatives space.